Skip to content
Search

Latest Stories

NHS: Dr. Sue Mann appointed as the inaugural National Clinical Director for Women's Health

NHS: Dr. Sue Mann appointed as the inaugural National Clinical Director for Women's Health

Dr. Mann's appointment coincides with the recruitment of six other National Clinical Directors

The National Health Service (NHS) has made a historic decision to appoint Dr. Sue Mann as its inaugural National Clinical Director for Women’s Health, marking a significant step forward in improving women’s healthcare services across England.


The announcement follows the recent confirmation of 18 National Clinical Directors as part of the 2024 cohort and coincides with six other recruitments.

Dr. Mann, a distinguished consultant and lead for women’s health in City and Hackney, North East London, brings with her a wealth of experience and expertise to this pivotal role.

Her responsibilities will include spearheading the strategy and facilitating the establishment of women’s health hubs throughout England to address various women's health concerns comprehensively, including menstrual health services and menopause assessment and treatment.

Additionally, Dr. Mann will collaborate with local care systems to establish a network of Women’s Health Champions, composed of senior leaders dedicated to advancing women’s health initiatives at the grassroots level.

Dr. Mann's previous contributions to women’s healthcare, such as pioneering Women’s Health Hubs and Virtual Group Consultations, highlight her innovative approach and dedication to improving healthcare delivery for women.

These initiatives, which are featured in the Women’s Health Strategy, underscore Dr. Mann's capacity to drive positive change in the field.

Expressing her enthusiasm for the new role, Dr. Mann emphasized her commitment to addressing the challenges faced by women in accessing quality healthcare:

"Having spent my career researching, treating, and developing policy and initiatives focused on women’s health, I have seen firsthand the challenges many women face, as well as the progress that has been made through better understanding and awareness of conditions affecting women."

Government officials have praised Dr. Mann's appointment as a significant step towards achieving the objectives outlined in the Women’s Health Strategy.

Minister for Women’s Health Strategy Maria Caulfield highlighted the pivotal role Dr. Mann will play in ensuring women's needs remain central to decision-making processes.

Dr. Mann's appointment signifies a significant milestone in the NHS's ongoing efforts to prioritize women’s health and underscores its commitment to delivering equitable and inclusive healthcare services for all.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less